Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders

The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse effects. The endocannabinoid system (ECS) components have gained high interest as potential new targets for treating psychiatry diseases because of their neuromodulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro, Daniela, Gasparyan, Ani, Navarrete, Francisco, Torregrosa, Abraham B., Rubio, Gabriel, Marín-Mayor, Marta, Acosta, Gabriela B., Garcia-Gutiérrez, Maria Salud, Manzanares, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104141/
https://www.ncbi.nlm.nih.gov/pubmed/35563156
http://dx.doi.org/10.3390/ijms23094764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104141/
https://www.ncbi.nlm.nih.gov/pubmed/35563156
http://dx.doi.org/10.3390/ijms23094764

Ejemplares similares